The firm presently has a $2.25 target price on the biotechnology company’s stock. Zacks Investment Research’s price objective would indicate a …
12
Dec
Leave a Reply
You must be logged in to post a comment.
The firm presently has a $2.25 target price on the biotechnology company’s stock. Zacks Investment Research’s price objective would indicate a …
You must be logged in to post a comment.